COVID-19

With advanced X-rays and blood biomarkers, researchers have found how lung tissue scarring in patients with COVID and pulmonary fibrosis forms a distinctive form of fibrotic interstitial lung disease, according to a study in eBioMedicine.

A higher bacterial and fungal lung microbiota burden in patients with COVID-19 was linked to nonresolving acute respiratory distress syndrome, according to a study published in American Journal of Respiratory and Critical Care Medicine.

New data published in an MMWR report showed that patients with COVID-19 given a prescription for Paxlovid had a lower rate of hospitalization.

CHICAGO — Short-term outcomes in heart transplant recipients who received hearts from people who were COVID-19 positive are “reassuring,” researchers reported at the American Heart Association Scientific Sessions.

NASHVILLE, Tenn. — Combination therapy with remdesivir and dexamethasone plus tocilizumab yielded reductions in inflammatory markers and mortality and more discharges for patients with COVID-19 hospitalized in the ICU, researchers reported.

In an interview with “60 Minutes” that aired on Sept. 18, President Joe Biden declared, “The pandemic is over.” And in some ways, he was correct.

Data from a phase 2/3 trial showed that Moderna’s bivalent COVID-19 booster shot outperformed the company’s original vaccine against SARS-CoV-2 omicron subvariants.

A surge of respiratory syncytial virus, an early start to influenza season and the ongoing COVID-19 pandemic have caused a “tripledemic” in the United States, overwhelming hospitals, experts said.

Even in cases of mild or asymptomatic COVID-19, severe disseminated intravascular coagulation was a possibility for pregnant people, findings from a retrospective case series show.

NEW YORK — In this video, Healio Pediatrics Peer Perspective Board Member C. Buddy Creech, MD, MPH, summarizes the “COVID corner” session at the Infectious Diseases in Children Symposium, including his own talk on outpatient treatment.